<div style="font-family: Times New Roman; font-size: 20px; padding-bottom:12px"><b>Highlights</b>:</div><div style="font-family: Times New Roman; font-size: 20px; padding-bottom:12px"> <ul style="list-style-type:disc;"><li> for the purposes of this paper , five have been identified : ( i ) the deficiency in the development and implementation of surveillance response systems against ebola and others infectious disease outbreaks in africa ; ( ii ) the lack of education and knowledge resulting in an evd outbreak triggering panic , anxiety , psychosocial trauma , isolation and dignity impounding , stigmatisation , community ostracism and resistance to associated socio - ecological and public health consequences ; ( iii ) limited financial resources , human technical capacity and weak community and national health system operational plans for prevention and control responses , practices and management ; ( iv ) inadequate leadership and coordination ; and ( v ) the lack of development of new strategies , tools and approaches , such as improved diagnostics and novel therapies including vaccines which can assist in preventing , controlling and containing ebola outbreaks as well as the spread of the disease .<font color='green'> score: 0.5650793883739557 </font> </li><li>novel coronavirus ( 2019 - ncov ) is an emerging pathogen that was first identified in wuhan , china in late december 2019 .<font color='#CCCC00'> score: 0.43851114017637116 </font> </li><li> [SEP][CLS]<font color='red'> score: -1.0 </font> </li></ul> </div><div style="font-family: Times New Roman; font-size: 18px; padding-bottom:12px"><b>Document</b>: Ernest Tambo et al. et al. Need of surveillance response systems to combat Ebola outbreaks and other emerging infectious diseases in African countries. <a href="https://doi.org/10.1186/2049-9957-3-29" target="_blank">source</a> Confidence: 0.5650793883739557</div><div style="font-family: Times New Roman; font-size: 16px; padding-bottom:12px"><b>Abstract</b>: there is growing concern in sub - saharan africa about the spread of the ebola virus disease ( evd ) , formerly known as ebola haemorrhagic fever , and the public health burden that it ensues . since 1976 , there have been 885 , 343 suspected and laboratory confirmed cases of evd and the disease has claimed 2 , 512 cases and 932 fatality in west africa . there are certain requirements that must be met when responding to evd outbreaks and this process could incur certain challenges . <font color='red'> for the purposes of this paper , five have been identified : ( i ) the deficiency in the development and implementation of surveillance response systems against ebola and others infectious disease outbreaks in africa ; ( ii ) the lack of education and knowledge resulting in an evd outbreak triggering panic , anxiety , psychosocial trauma , isolation and dignity impounding , stigmatisation , community ostracism and resistance to associated socio - ecological and public health consequences ; ( iii ) limited financial resources , human technical capacity and weak community and national health system operational plans for prevention and control responses , practices and management ; ( iv ) inadequate leadership and coordination ; and ( v ) the lack of development of new strategies , tools and approaches , such as improved diagnostics and novel therapies including vaccines which can assist in preventing , controlling and containing ebola outbreaks as well as the spread of the disease .</font>  hence , there is an urgent need to develop and implement an active early warning alert and surveillance response system for outbreak response and control of emerging infectious diseases . understanding the unending risks of transmission dynamics and resurgence is essential in implementing rapid effective response interventions tailored to specific local settings and contexts . therefore , the following actions are recommended : ( i ) national and regional inter - sectorial and trans - disciplinary surveillance response systems that include early warnings , as well as critical human resources development , must be quickly adopted by allied ministries and organisations in african countries in epidemic and pandemic responses ; ( ii ) harnessing all stakeholders commitment and advocacy in sustained funding , collaboration , communication and networking including community participation to enhance a coordinated responses , as well as tracking and prompt case management to combat challenges ; ( iii ) more research and development in new drug discovery and vaccines ; and ( iv ) understanding the involvement of global health to promote the establishment of public health surveillance response systems with functions of early warning , as well as monitoring and evaluation in upholding research - action programmes and innovative interventions . [SEP]</div><div style="font-family: Times New Roman; font-size: 18px; padding-bottom:12px"><b>Document</b>: Balamurugan Shanmugaraj et al. et al. Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development. <a href="https://doi.org/10.3390/pathogens9020148" target="_blank">source</a> Confidence: 0.43851114017637116</div><div style="font-family: Times New Roman; font-size: 16px; padding-bottom:12px"><b>Abstract</b>:  <font color='red'>novel coronavirus ( 2019 - ncov ) is an emerging pathogen that was first identified in wuhan , china in late december 2019 .</font>  this virus is responsible for the ongoing outbreak that causes severe respiratory illness and pneumonia - like infection in humans . due to the increasing number of cases in china and outside china , the who declared coronavirus as a global health emergency . nearly 35 , 000 cases were reported and at least 24 other countries or territories have reported coronavirus cases as early on as february . inter - human transmission was reported in a few countries , including the united states . neither an effective anti - viral nor a vaccine is currently available to treat this infection . as the virus is a newly emerging pathogen , many questions remain unanswered regarding the virus ' s reservoirs , pathogenesis , transmissibility , and much more is unknown . the collaborative efforts of researchers are needed to fill the knowledge gaps about this new virus , to develop the proper diagnostic tools , and effective treatment to combat this infection . recent advancements in plant biotechnology proved that plants have the ability to produce vaccines or biopharmaceuticals rapidly in a short time . in this review , the outbreak of 2019 - ncov in china , the need for rapid vaccine development , and the potential of a plant system for biopharmaceutical development are discussed . [SEP]</div>